Roche Holding (VTX: ROG)‘s stock had its “reduce” rating restated by investment analysts at AlphaValue in a note issued to investors on Thursday, Stock Ratings Network reports. They currently have a CHF 237 price objective on the stock.
Shares of Roche Holding (VTX: ROG) traded down 0.57% during mid-day trading on Thursday, hitting CHK 226.90. Roche Holding has a 52 week low of CHK 155.50 and a 52 week high of CHK 258.60. The stock’s 50-day moving average is currently CHK 0..
Other equities research analysts have also recently issued reports about the stock. Analysts at Natixis reiterated a “buy” rating on shares of Roche Holding in a research note to investors on Tuesday, June 4th. They now have a CHF 270 price target on the stock. Separately, analysts at Sanford C. Bernstein reiterated an “outperform” rating on shares of Roche Holding in a research note to investors on Monday, June 3rd. They now have a CHF 247 price target on the stock. Finally, analysts at Independent Research GmbH reiterated a “hold” rating on shares of Roche Holding in a research note to investors on Wednesday, May 29th.
One analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. Roche Holding has a consensus rating of “Hold” and a consensus target price of €264.17 ($343.07).
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world.